Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Relay Therapeutics Inc. Common Stock (RLAY) vs Consumer Discretionary Select Sector SPDR Fund (XLY) Price & Performance

Relay Therapeutics Inc. Common StockTrade
Consumer Discretionary Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Relay Therapeutics Inc. Common Stock vs Consumer Discretionary Select Sector SPDR Fund — how do they compare? Relay Therapeutics Inc. Common Stock trades at $18.28 (market cap $3.82B), while Consumer Discretionary Select Sector SPDR Fund trades at $112.74 (market cap $21.89B). The key difference: Consumer Discretionary Select Sector SPDR Fund is far larger — about 5.7× Relay Therapeutics Inc. Common Stock's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Consumer Discretionary Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Consumer Discretionary Select Sector SPDR Fund for 114 Days on average.

RLAYXLY
Market Cap
$3.82B$21.89B
Volume
4,332,0795,690,342
Sector
Health—
52-Week High
$20.75$124.52
52-Week Low
$6.03$105.64
Typical Hold Time
0 Days114 Days
Enterprise Value
$2.93B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Relay Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Consumer Discretionary Select Sector SPDR Fund

XLY trades at $112.72, up 1.22% today, with a bullish technical signal despite mixed moving average and oscillator readings. The ETF shows strong analyst support with a 100% buy rating from coverage, though recent underperformance versus consumer staples highlights sector rotation pressures. Key technical levels show support at $110-$111 and resistance at $112-$113, with RSI indicating potential overbought conditions on shorter timeframes.

Outlook remains cautiously optimistic given analyst consensus, but investors face headwinds from inflation pressures on discretionary spending and ongoing underperformance versus broader market. The 'funflation' trend supporting consumer leisure spending provides potential upside, though valuation metrics remain unavailable for comprehensive assessment.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RLAY
100% Buy0% Sell
Avg holding period · 0 Days
XLY

No sentiment data available yet.

About Relay Therapeutics Inc. Common Stock

Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.

Read more on RLAY →

About Consumer Discretionary Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: retail; hotels, restaurants and leisure; textiles, apparel and luxury goods; household durables; automobiles; auto components; distributors; leisure products; and diversified consumer services. It is non-diversified.

Read more on XLY →